[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]

[[ timeLabel ]] WATCH LIVE:

Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial

Faster, Cleaner, Better.

Respirerx Pharmaceuticals Inc (RSPI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Cash Flow for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	06-2002	03-2002	12-2001	09-2001	06-2001
Cash Flows From Operating Activities
Net Income	N/A	-600	240	1,196	N/A
Depreciation Amortization	N/A	115	77	39	N/A
Accounts receivable	N/A	-378	-91	-2,039	N/A
Other Working Capital	N/A	-1,770	-1,771	-2,654	N/A
Other Operating Activity	0	545	295	2,085	0
Operating Cash Flow	$N/A	$-2,089	$-1,250	$-1,372	$N/A

Cash Flows From Investing Activities
PPE Investments	N/A	-90	-54	-33	N/A
Investing Cash Flow	$N/A	$-90	$-54	$-33	$N/A

Cash Flows From Financing Activities
Common Stock Issued	N/A	91	N/A	N/A	N/A
Dividend Paid	N/A	-1	-1	N/A	N/A
Financing Cash Flow	$N/A	$90	$-1	$N/A	$N/A

Beginning Cash Position	N/A	4,558	4,558	4,558	N/A
End Cash Position	N/A	2,469	3,253	3,152	N/A
Net Cash Flow	$N/A	$-2,088	$-1,305	$-1,405	$N/A

Free Cash Flow
Operating Cash Flow	N/A	-2,089	-1,250	-1,372	N/A
Capital Expenditure	N/A	-90	-54	-33	N/A
Free Cash Flow	0	-2,178	-1,304	-1,405	0